COMMUNIQUÉS West-GlobeNewswire

Rejuvant Emerges as No. 1 Longevity Solution in TruMe Labs DNA Methylation Test Results
24/01/2024
FERNANDINA BEACH, Fla., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Ponce de Leon Health, the creators of Rejuvant , revealed vital insights for longevity enthusiasts in a LinkedIn post published by its founder and CEO, Tom [...]
500th Use of the Galaxy System™ in the United States Conducted at CHI Memorial in Tennessee
24/01/2024
The procedure marks an important achievement as the Noah Galaxy System’s imaging-integrated robot-assisted bronchoscopy solution continues to roll out to health systems and physicians across the U.S. SAN CARLOS, Calif [...]
PharmAla receives new “MDXXF” ticker from FINRA for OTCQB Listing
24/01/2024
New ticker symbol goes into effect immediately VANCOUVER, British Columbia, Jan. 24, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology [...]
Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2
24/01/2024
-Project NextGen Collaboration will Support Capricor’s StealthX™ Exosome Platform and Provide Non-Dilutive Support for Advancement into the Clinic- SAN DIEGO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics ( [...]
AIM ImmunoTech Receives Erasmus Medical Center Ethics Board Authorization for Phase 2 Study of Ampligen® for the Treatment of Locally Advanced Pancreatic Cancer
24/01/2024
Subject enrollment is expected in Q1 2024 OCALA, Fla., Jan. 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has received authorization from the [...]
HWH International Provides Business Status Update
24/01/2024
Bethesda, MD, Jan. 24, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (Nasdaq: HWH) (“HWH”) is pleased to offer an update on HWH's business operations since the successful completion of the business combination on [...]
ProLynx announces a publication proposing that a long-acting prodrug of SN-38 could be effective in treating Sacituzumab Govitecan-Resistant Tumors
24/01/2024
SAN FRANCISCO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- ProLynx Inc., a biotech company with a unique technology for tunable half-life extension of drugs, announced publication of a paper entitled “Could a Long-Acting Prodrug [...]
Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
24/01/2024
HAMILTON, BERMUDA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Altamira’s poly KRAS mut siRNA shown to knock down at least 65-91% of KRAS mutations in colorectal, non-small cell lung, and pancreatic cancer cell lines Fresh [...]
Immix Biopharma Statement On January 2024 FDA Labeling Change Notification For Approved CAR-T Products
24/01/2024
LOS ANGELES, CA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Immix Biopharma”, “Company”, “We” or “Us”, Nasdaq:IMMX), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune [...]
Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
24/01/2024
Tailored Vaccines: With the AI-Immunology™ enabled discovery of these novel types of cancer vaccine targets, designing personalized and precision vaccine solutions becomes feasible and highly promising for patients in [...]
nmible partners with Velocity Clinical Research to streamline clinical trials patient stipends
24/01/2024
• nmible’s solution expected to save more than 650 working days per year, administering payments • Velocity spends $20 million a year in patient stipends LONDON, Jan. 24, 2024 (GLOBE NEWSWIRE) -- U.K.-based nmible, the [...]
CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b
24/01/2024
- Initiation of CX-2051 Phase 1 clinical study in EpCAM positive tumors including colorectal cancer anticipated in 1H 2024 - - Initiation of CX-801 Phase 1 clinical study in solid tumors including melanoma, renal, and [...]
TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference
24/01/2024
FORT WORTH, Texas, Jan. 24, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its [...]
Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data Announcement
24/01/2024
MALVERN, Pa., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, has announced a postponement in the Phase [...]
Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer
24/01/2024
REDWOOD CITY, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare [...]
Soleno Therapeutics Strengthens Leadership Team with Key Appointments
24/01/2024
REDWOOD CITY, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
24/01/2024
MOUNTAIN VIEW, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation, headquartered in Mountain View, California, and Imperial College Healthcare NHS Trust in London, today announced the first patient enrollment [...]
Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing
24/01/2024
Pre-print publication from Levy, et al. describes the second phase of a multisite evaluation and validation of optical genome mapping (OGM) that is designed to measure the workflow’s accuracy and clinical utility [...]
HealthLynked and CEO Dr. Michael Dent Featured in Health Documentary "Forever: The End of Aging," Now Available for Streaming
24/01/2024
HealthLynked and CEO Dr. Michael Dent Featured in Health Documentary "Forever: The End of Aging," Now Available for Streaming NAPLES, Fla., Jan. 24, 2024 (GLOBE NEWSWIRE) -- – via IBN – HealthLynked Corp. ( OTCQB: HLYK [...]

Pages